Literature DB >> 26233594

Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial.

Gökay Görmeli1, Cemile Ayşe Görmeli2, Baybars Ataoglu3, Cemil Çolak4, Okan Aslantürk5, Kadir Ertem5.   

Abstract

PURPOSE: To compare the effectiveness of intraarticular (IA) multiple and single platelet-rich plasma (PRP) injections as well as hyaluronic acid (HA) injections in different stages of osteoarthritis (OA) of the knee.
METHODS: A total of 162 patients with different stages of knee OA were randomly divided into four groups receiving 3 IA doses of PRP, one dose of PRP, one dose of HA or a saline injection (control). Then, each group was subdivided into two groups: early OA (Kellgren-Lawrence grade 0 with cartilage degeneration or grade I-III) and advanced OA (Kellgren-Lawrence grade IV). The patients were evaluated before the injection and at the 6-month follow-ups using the EuroQol visual analogue scale (EQ-VAS) and International Knee Documentation Committee (IKDC) subjective scores. Adverse events and patient satisfaction were recorded.
RESULTS: There was a statistically significant improvement in the IKDC and EQ-VAS scores in all the treatment groups compared with the control group. The knee scores of patients treated with three PRP injections were significantly better than those patients of the other groups. There was no significant difference in the scores of patients injected with one dose of PRP or HA. In the early OA subgroups, significantly better clinical results were achieved in the patients treated with three PRP injections, but there was no significant difference in the clinical results of patients with advanced OA among the treatment groups.
CONCLUSION: The clinical results of this study suggest IA PRP and HA treatment for all stages of knee OA. For patients with early OA, multiple (3) PRP injections are useful in achieving better clinical results. For patients with advanced OA, multiple injections do not significantly improve the results of patients in any group. LEVEL OF EVIDENCE: I.

Entities:  

Keywords:  Hyaluronic acid; Intraarticular injection; Knee osteoarthritis; Platelet-rich plasma

Mesh:

Substances:

Year:  2015        PMID: 26233594     DOI: 10.1007/s00167-015-3705-6

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  33 in total

1.  Cartilage injuries: a review of 31,516 knee arthroscopies.

Authors:  W W Curl; J Krome; E S Gordon; J Rushing; B P Smith; G G Poehling
Journal:  Arthroscopy       Date:  1997-08       Impact factor: 4.772

2.  Sorbitol-modified hyaluronic acid reduces oxidative stress, apoptosis and mediators of inflammation and catabolism in human osteoarthritic chondrocytes.

Authors:  John-Max Mongkhon; Maryane Thach; Qin Shi; Julio C Fernandes; Hassan Fahmi; Mohamed Benderdour
Journal:  Inflamm Res       Date:  2014-05-25       Impact factor: 4.575

3.  Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial.

Authors:  Sandeep Patel; Mandeep S Dhillon; Sameer Aggarwal; Neelam Marwaha; Ashish Jain
Journal:  Am J Sports Med       Date:  2013-01-08       Impact factor: 6.202

4.  Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration.

Authors:  Xuetao Xie; Yang Wang; Cunju Zhao; Shangchun Guo; Shen Liu; Weitao Jia; Rocky S Tuan; Changqing Zhang
Journal:  Biomaterials       Date:  2012-07-19       Impact factor: 12.479

5.  Intra-articular hylastan versus steroid for knee osteoarthritis.

Authors:  Lawrence Housman; Nigel Arden; Thomas J Schnitzer; Charles Birbara; Thierry Conrozier; Nebojsa Skrepnik; Nathan Wei; Barry Bockow; David Waddell; Hasan Tahir; Anthony Hammond; Philippe Goupille; Bernd-Jan Sanson; Clare Elkins; François Bailleul
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-02-16       Impact factor: 4.342

6.  Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.

Authors:  Emily A Sundman; Brian J Cole; Lisa A Fortier
Journal:  Am J Sports Med       Date:  2011-08-16       Impact factor: 6.202

7.  Intra-articular corticosteroids in arthritic disease: a guide to treatment.

Authors:  M Ostergaard; P Halberg
Journal:  BioDrugs       Date:  1998-02       Impact factor: 5.807

8.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

9.  Platelet-rich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1-year follow-up.

Authors:  Serdar Kesikburun; Arif Kenan Tan; Bilge Yilmaz; Evren Yaşar; Kamil Yazicioğlu
Journal:  Am J Sports Med       Date:  2013-07-26       Impact factor: 6.202

10.  Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee.

Authors:  M Saito; K A Takahashi; Y Arai; A Inoue; K Sakao; H Tonomura; K Honjo; S Nakagawa; H Inoue; Y Tabata; T Kubo
Journal:  Clin Exp Rheumatol       Date:  2009 Mar-Apr       Impact factor: 4.473

View more
  100 in total

Review 1.  Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee.

Authors:  Wichan Kanchanatawan; Alisara Arirachakaran; Kornkit Chaijenkij; Niti Prasathaporn; Manusak Boonard; Peerapong Piyapittayanun; Jatupon Kongtharvonskul
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-09-19       Impact factor: 4.342

2.  PRP: Product Rich in Placebo?

Authors:  Giuseppe Filardo; Elizaveta Kon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-12       Impact factor: 4.342

3.  Choice of intra-articular injection in treatment of knee osteoarthritis: platelet-rich plasma, hyaluronic acid or ozone options.

Authors:  Tahir Mutlu Duymus; Serhat Mutlu; Bahar Dernek; Baran Komur; Suavi Aydogmus; Fatma Nur Kesiktas
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-07       Impact factor: 4.342

Review 4.  Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis.

Authors:  Kim L Bennell; David J Hunter; Kade L Paterson
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

Review 5.  The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders.

Authors:  Matthew J Kraeutler; Tigran Garabekyan; Omer Mei-Dan
Journal:  Muscles Ligaments Tendons J       Date:  2016-12-21

6.  Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis.

Authors:  Ron Gilat; Eric D Haunschild; Derrick M Knapik; Aghogho Evuarherhe; Kevin C Parvaresh; Brian J Cole
Journal:  Int Orthop       Date:  2020-09-15       Impact factor: 3.075

Review 7.  Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee.

Authors:  Corey S Cook; Patrick A Smith
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 8.  Current Clinical Recommendations for Use of Platelet-Rich Plasma.

Authors:  Adrian D K Le; Lawrence Enweze; Malcolm R DeBaun; Jason L Dragoo
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 9.  Quality assurance and adverse event management in regenerative medicine for knee osteoarthritis: Current concepts.

Authors:  Maimuna Marenah; Jinjie Li; Ashok Kumar; William Murrell
Journal:  J Clin Orthop Trauma       Date:  2018-09-18

Review 10.  Innovative regenerative medicine in the management of knee OA: The role of Autologous Protein Solution.

Authors:  Nicolò Danilo Vitale; Filippo Vandenbulcke; Emanuele Chisari; Francesco Iacono; Laura Lovato; Berardo Di Matteo; Elizaveta Kon
Journal:  J Clin Orthop Trauma       Date:  2018-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.